Mesenchymal stem cells/marrow stromal cells (MSCs) present a promising tool for cell
therapy, and are currently being tested in US FDA-approved clinical trials for myocardial …

Tissue engineering is a newly emerging biomedical technology, which aids and increases
the repair and regeneration of deficient and injured tissues. It employs the principles from …

Recently, mesenchymal stromal cell (MSC)-based therapy has become an appreciated
therapeutic approach in the context of neurodegenerative disease therapy. Accordingly, a …

Mesenchymal Stem Cells or Marrow Stromal Cells (MSCs) have long been viewed as a
potent tool for regenerative cell therapy. MSCs are easily accessible from both healthy donor …

No long term effective treatments are currently available for brain neurological disorders
such as stroke/cerebral ischemia, traumatic brain injury and neurodegenerative disorders …

We investigated the therapeutic potential of human bone marrow-derived mesenchymal
stem cells (hBM-MSCs) in Huntington's disease (HD) mouse models. Ten weeks after …

There is much interest in the use of mesenchymal stem cells/marrow stromal cells (MSC) to
treat neurodegenerative disorders, in particular those that are fatal and difficult to treat, such …

Transplantation of mesenchymal stem cells (MSCs) into the injured brain may provide
therapeutic benefits. Several models of brain diseases have been examined, including that …

Bone marrow mesenchymal stem cells (MSC) have been tested and proven effective in
some neurodegenerative diseases, but their tracking after transplantation may be …

Introduction Huntington's disease (HD) is an autosomal dominant disorder caused by an
expanded CAG repeat (greater than 38) on the short arm of chromosome 4, resulting in loss …